首页 | 本学科首页   官方微博 | 高级检索  
     检索      

心房纤颤治疗新进展
引用本文:李春玲.心房纤颤治疗新进展[J].天津科技大学学报,1999(2):37-40.
作者姓名:李春玲
作者单位:天津轻工业学院校医院
摘    要:房颤是一种常见的心律失常,其发病率随年龄的增加而升高,目前高血压、冠心病已逐渐成为老年房颤的最常见原因,现已公认房颤与脑卒中有很大关系,所以房颤病人进行转复治疗尤其抗凝治疗具特殊意义。在抗凝治疗过程中,应结合患者的年龄、临床危险因素及抗凝治疗的益处和潜在危险,合理使用抗凝药物。抗凝治疗有预防栓塞的作用,从而能显著降低卒中的发病率

关 键 词:心房纤颤  卒中  抗凝治疗
修稿时间::1999年1月19

NEW PROGRESS IN ATRIAL FIBRILLATION THERAPY
Li Chunling.NEW PROGRESS IN ATRIAL FIBRILLATION THERAPY[J].Journal of Tianjin University of Science & Technology,1999(2):37-40.
Authors:Li Chunling
Institution:Li Chunling
Abstract:Atrial fibrillation is happened arrhythmia frequently.The incidence of the disease will increase as the age increases.At present,hypertension,coronary heart disease are the main factors causing the aged people to catch atrial fibrillation.It has been proved that atrial fibrillation is related very much to stroke.So it is of great significance for the patients who have caught atrial fibrillation to be treated with anticoagulant therapy.as well as Cardioversion treatment.In the couse of anticoagulant therapy,the anticoagulants should be used according to the patients age,clinical danger as well as the advantage and potential danger of the anticoagulative therapy.Anticoagulative therapy plays an important role in preventing thrombosis,so as to lower the morbidity of stroke.
Keywords:Atrial fibrillation  Stroke  Anticoagulant therapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号